We are live on ! Find out more
ONC

BeOne Medicines Ltd

208 hedge funds and large institutions have $8.4B invested in BeOne Medicines Ltd in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% more ownership

Funds ownership: 3.52%3.77% (+0.25%)

7% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 69

5% less funds holding

Funds holding: 219208 (-11)

18% less capital invested

Capital invested by funds: $10.3B → $8.4B (-$1.9B)

27% less funds holding in top 10

Funds holding in top 10: 118 (-3)

29% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 38

64% less call options, than puts

Call options by funds: $10.8M | Put options by funds: $29.9M

Holders
208
Holders Change
-11
Holders Change %
-5.02%
% of All Funds
3.27%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.13%
New
27
Increased
64
Reduced
69
Closed
38
Calls
$10.8M
Puts
$29.9M
Net Calls
-$19.1M
Net Calls Change
-$38.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Stifel Financial
76
Stifel Financial
Missouri
$2.52M -$330K -1,434 -9%
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
$2.49M -$183K -793 -6%
EAM
78
Erste Asset Management
Austria
$2.25M
American Century Companies
79
American Century Companies
Missouri
$2.19M
Dimensional Fund Advisors
80
Dimensional Fund Advisors
Texas
$2.18M -$63.3K -275 -2%
BA
81
Bridgewater Associates
Connecticut
$2.16M -$27.6M -119,999 -91%
NFGH
82
Nan Fung Group Holdings
Hong Kong
$2.14M
OAM
83
Oppenheimer Asset Management
New York
$2.11M +$99K +430 +4%
KBC Group
84
KBC Group
Belgium
$2.02M
AG
85
AIA Group
Hong Kong
$1.85M +$1.29M +5,621 +119%
BG
86
Bellevue Group
Switzerland
$1.82M -$11.1M -48,035 -82%
CG
87
Colony Group
Massachusetts
$1.82M +$230 +1 +0%
AssetMark Inc
88
AssetMark Inc
California
$1.7M +$210K +914 +11%
EAM
89
EFG Asset Management
Oregon
$1.68M +$2.17M +9,444 New
State Street
90
State Street
Massachusetts
$1.68M -$59.1M -256,808 -96%
Renaissance Technologies
91
Renaissance Technologies
New York
$1.66M +$2.14M +9,300 New
Northern Trust
92
Northern Trust
Illinois
$1.63M +$53.4K +232 +3%
PAM
93
Pinpoint Asset Management
Hong Kong
$1.61M +$944K +4,098 New
IBT
94
International Biotechnology Trust
United Kingdom
$1.55M -$3.22M -14,000 -62%
Squarepoint
95
Squarepoint
New York
$1.5M +$1.06M +4,594 +119%
Fiera Capital (Canada)
96
Fiera Capital (Canada)
Quebec, Canada
$1.49M -$43.3K -188 -2%
Bank of New York Mellon
97
Bank of New York Mellon
New York
$1.12M -$110K -477 -7%
PL
98
Parkwood LLC
Ohio
$1.07M +$181K +784 +15%
CCIA
99
Campbell & Co Investment Adviser
Maryland
$1.04M +$1.35M +5,850 New
SAM
100
Sectoral Asset Management
Quebec, Canada
$1.03M +$66.8K +290 +5%

ONC Hedge Fund Activity: Q2 2023 in Review

208 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2023, worth a combined $8.4B — down 18% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of ONC and 27 opened new positions — a net loss of 11 holders — while 69 trimmed existing stakes and 64 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $163M. The largest seller was HHLR Advisors, cutting an estimated $68M.

  • 208 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $8.4B of BeOne Medicines Ltd stock for Q2 2023, down 18% quarter-over-quarter.
  • 27 funds opened new BeOne Medicines Ltd positions in Q2 2023 and 38 closed out, a net change of -11 holders.
  • The largest BeOne Medicines Ltd buyer in Q2 2023 was T. Rowe Price Associates, an estimated $163M added.
  • The largest BeOne Medicines Ltd seller in Q2 2023 was HHLR Advisors, an estimated $68M sold.

Based on aggregated 13F filings for Q2 2023.